nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Head-to-Head Comparison of the Standard Quality-Adjusted Life Year Model With the Annual Profile Model
|
Janssen, Mathieu F. |
|
|
24 |
5 |
p. 707-713 |
artikel |
2 |
A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies
|
Nguyen, Anh Le Tuan |
|
|
24 |
5 |
p. 733-743 |
artikel |
3 |
Budget Impact of Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia With Sustained Deep Molecular Response
|
Astrugue, Cyril |
|
|
24 |
5 |
p. 683-690 |
artikel |
4 |
Copyright/Subscription
|
|
|
|
24 |
5 |
p. v |
artikel |
5 |
Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial
|
Marguet, Sophie |
|
|
24 |
5 |
p. 676-682 |
artikel |
6 |
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
|
Schneider, Paul Peter |
|
|
24 |
5 |
p. 668-675 |
artikel |
7 |
Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
|
Zhao, Jidi |
|
|
24 |
5 |
p. 615-624 |
artikel |
8 |
Editorial Board
|
|
|
|
24 |
5 |
p. vi |
artikel |
9 |
Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
|
Chhatwal, Jagpreet |
|
|
24 |
5 |
p. 605-606 |
artikel |
10 |
HIV Pre-Exposure Prophylaxis, Condoms, or Both? Insights on Risk Compensation Through a Discrete Choice Experiment and Latent Class Analysis Among Men Who Have Sex With Men
|
Tan, Rayner Kay Jin |
|
|
24 |
5 |
p. 714-723 |
artikel |
11 |
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
|
Towse, Adrian |
|
|
24 |
5 |
p. 625-631 |
artikel |
12 |
Intraindividual Comparisons to Determine Comparative Effectiveness: Their Relevance for G-BA’s Health Technology Assessments
|
Wagle, Julia Annabel |
|
|
24 |
5 |
p. 744-752 |
artikel |
13 |
Joint Longitudinal Models for Dealing With Missing at Random Data in Trial-Based Economic Evaluations
|
Gabrio, Andrea |
|
|
24 |
5 |
p. 699-706 |
artikel |
14 |
Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study
|
Gravesteijn, Benjamin |
|
|
24 |
5 |
p. 648-657 |
artikel |
15 |
Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis
|
Shlomai, Amir |
|
|
24 |
5 |
p. 607-614 |
artikel |
16 |
Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States
|
Basu, Anirban |
|
|
24 |
5 |
p. 632-640 |
artikel |
17 |
Smoking Cessation and Quality of Life: Insights From Analysis of Longitudinal Australian Data, an Application for Economic Evaluations
|
Moayeri, Foruhar |
|
|
24 |
5 |
p. 724-732 |
artikel |
18 |
Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands
|
Mouter, Niek |
|
|
24 |
5 |
p. 658-667 |
artikel |
19 |
Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs
|
Manski, Charles F. |
|
|
24 |
5 |
p. 641-647 |
artikel |
20 |
Table of Contents
|
|
|
|
24 |
5 |
p. i-iv |
artikel |
21 |
10 Years of End-of-Life Criteria in the United Kingdom
|
Bovenberg, Josien |
|
|
24 |
5 |
p. 691-698 |
artikel |